Related Experiment Video

Updated: Apr 29, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.9K

F-01A, an antibiotic, inhibits lung cancer cells proliferation

Jing Wang1, Xiao-Peng Wu2, Xin-Ming Song3

  • 1Key Laboratory of Tropical Medicinal Plant Chemistry of Ministry of Education, Hainan Normal University, Haikou 571158, China; College of Life Sciences, Hainan Normal University, Haikou 571158, China.

Chinese Journal of Natural Medicines
|May 28, 2014
PubMed
Abstract

Insights

The novel antibiotic F-01A effectively induces apoptosis in lung cancer cells (SPC-A-1) through a dose-dependent mitochondrial pathway. This compound shows significant potential for further development as an anticancer therapeutic.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Lung cancer remains a leading cause of cancer-related mortality worldwide.
  • Identification of novel small molecules with antiproliferative activity is crucial for advancing lung cancer treatment.

Purpose of the Study:

  • To investigate the antitumor properties of F-01A, a polyether antibiotic, against human lung cancer cells.
  • To elucidate the mechanism of action of F-01A in inducing cancer cell death.

Main Methods:

  • F-01A was tested on the SPC-A-1 lung cancer cell line at various concentrations.
  • Cell viability was assessed using MTT assay.
  • Apoptosis was evaluated through nuclear morphology, DNA fragmentation, and mitochondrial membrane potential assays.

Main Results:

  • F-01A demonstrated dose-dependent induction of apoptosis in SPC-A-1 cells.
  • The half-maximal inhibitory concentration (IC50) was determined to be 0.65 μmol·L(-1).
  • F-01A treatment led to loss of mitochondrial membrane potential and DNA fragmentation, indicative of apoptosis.

Conclusions:

  • F-01A induces apoptosis in lung cancer cells, likely via the mitochondrial pathway.
  • The findings suggest F-01A has significant antitumor potential and warrants further investigation for drug development.
  • F-01A activates apoptotic pathways, offering a promising avenue for novel lung cancer therapies.
Keywords:
ApoptosisMembrane potentialPolyether antibioticSPC-A-1 cells

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

9.7K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

8.1K

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
102
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
181
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
125
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K